
Over-The-Counter (OTC) Artificial Tears Market Report 2026
Global Outlook – By Type (Cellulose Derived Tears, Glycerin Derived Tears, Oil-Based Emulsion Tears, Polyethylene Glycol), By Container Type (Plastic Single Dose Container, Plastic Multi-Dose Container, Other Container Types), By Formulation (Preservative Based, Non-Preservative Based), By Application (Dry Eye Syndrome, Allergies, Ultraviolet (UV) And Blue Light Protection, Contact Lens Moisture Retention, Other Applications), By Distribution Channel (Hospital Pharmacies, Drug Store And Retail Pharmacies, Online Pharmacies) – Market Size, Trends, Strategies, and Forecast to 2035
Over-The-Counter (OTC) Artificial Tears Market Overview
• Over-The-Counter (OTC) Artificial Tears market size has reached to $4.94 billion in 2025 • Expected to grow to $6.53 billion in 2030 at a compound annual growth rate (CAGR) of 5.7% • Growth Driver: Rising Eye Disease Prevalence Fueling The Growth Of The Market Due To Increasing Demand For Vision Care Solutions • Market Trend: Advancements In Preservative-Free Formulations Enhance Long-Lasting Relief For Dry Eye Disease • North America was the largest region in 2025 and Europe is the fastest growing region.What Is Covered Under Over-The-Counter (OTC) Artificial Tears Market?
Over-the-counter artificial tears are non-prescription eye drops designed to lubricate and relieve dryness, irritation, or discomfort in the eyes caused by environmental factors, digital screen use, or medical conditions such as dry eye syndrome. These artificial tears provide quick, accessible relief and are widely used for routine eye hydration without a doctor’s prescription. The main types of over-the-counter (OTC) artificial tears are cellulose-derived tears, glycerin-derived tears, oil-based emulsion tears, and polyethylene glycol. Cellulose-derived tears are artificial tear solutions formulated using cellulose-based polymers to mimic natural tears and provide long-lasting moisture and lubrication for dry or irritated eyes. The multiple container types include plastic single-dose containers, plastic multi-dose containers, and others. The various formulations involved are preservative-based and non-preservative-based, and they are used in several applications such as dry eye syndrome, allergies, infections, ultraviolet (UV) and blue light protection, contact lens moisture retention, and others. The key distribution channels include hospital pharmacies, drugstores and retail pharmacies, and online pharmacies.
What Is The Over-The-Counter (OTC) Artificial Tears Market Size and Share 2026?
The over-the-counter (otc) artificial tears market size has grown strongly in recent years. It will grow from $4.94 billion in 2025 to $5.24 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to limited availability of non-prescription eye drops, growing awareness of eye health, increasing screen time among adults and children, reliance on conventional cellulose-based tears, expansion of hospital and retail pharmacy networks.What Is The Over-The-Counter (OTC) Artificial Tears Market Growth Forecast?
The over-the-counter (otc) artificial tears market size is expected to see strong growth in the next few years. It will grow to $6.53 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to development of glycerin and oil-based emulsion tears, rising adoption of polyethylene glycol formulations, increasing demand for contact lens moisture retention products, growth of online pharmacy channels, innovations in preservative-free and multi-dose packaging. Major trends in the forecast period include rising incidence of dry eye syndrome due to digital screen usage, increased demand for preservative-free formulations, growing preference for multi-dose and single-dose containers, expansion of online pharmacies and e-commerce distribution, awareness about uv and blue light protection for eye health.Global Over-The-Counter (OTC) Artificial Tears Market Segmentation
1) By Type: Cellulose Derived Tears, Glycerin Derived Tears, Oil-Based Emulsion Tears, Polyethylene Glycol 2) By Container Type: Plastic Single Dose Container, Plastic Multi-Dose Container, Other Container Types 3) By Formulation: Preservative Based, Non-Preservative Based 4) By Application: Dry Eye Syndrome, Allergies, Ultraviolet (UV) And Blue Light Protection, Contact Lens Moisture Retention, Other Applications 5) By Distribution Channel: Hospital Pharmacies, Drug Store And Retail Pharmacies, Online Pharmacies Subsegments: 1) By Cellulose Derived Tears: Hydroxypropyl Methylcellulose (HPMC), Carboxymethylcellulose (CMC), Hypromellose 2) By Glycerin Derived Tears: Pure Glycerin Formulations, Glycerin with Additional Lubricants, Glycerin Combined with Electrolytes 3) By Oil-Based Emulsion Tears: Mineral Oil Based, Castor Oil Based, Safflower Oil Based, Flaxseed Oil Based 4) By Polyethylene Glycol: Polyethylene Glycol 400, Polyethylene Glycol 800, Polyethylene Glycol with Propylene GlycolWhat Is The Driver Of The Over-The-Counter (OTC) Artificial Tears Market?
The increasing prevalence of eye disease is expected to propel the growth of the over-the-counter (OTC) artificial tears market going forward. An eye disease is a condition that impairs the normal function or structure of the eye, leading to vision problems or loss if untreated. The increasing prevalence of eye disease is due to aging populations more prone to vision problems, creating greater demand for advanced eye care solutions. Over-the-counter (OTC) artificial tears help manage eye disease by providing soothing lubrication that relieves dryness, reduces irritation, and helps protect the ocular surface to improve overall eye comfort. For instance, in August 2023, according to the World Health Organization, a Switzerland-based international public health organization, more than 2.2 billion people globally were living with near or distance vision impairment, with most cases occurring in adults over the age of 50. Therefore, the increasing prevalence of eye disease is driving the growth of the over-the-counter (OTC) artificial tears industry.Key Players In The Global Over-The-Counter (OTC) Artificial Tears Market
Major companies operating in the over-the-counter (otc) artificial tears market are AbbVie Inc., Abbott Laboratories Inc., Novartis AG, Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Cipla Limited, Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical Co. Ltd., Prestige Consumer Healthcare Inc., AFT Pharmaceuticals Limited, URSAPHARM Arzneimittel GmbH, OCuSOFT Inc., Laboratoires Théa S.A.S., I-MED Pharma Inc.Global Over-The-Counter (OTC) Artificial Tears Market Trends and Insights
Major companies operating in the over-the-counter artificial tears market are focusing on developing advanced preservative-free formulations, such as lipid layer stabilization formulas, to provide effective and long-lasting relief. Lipid layer stabilization is the process of strengthening the outer oily layer of the tear film to prevent rapid evaporation of tears and maintain eye moisture. For instance, in February 2025, Alcon Inc., a Switzerland-based eye care company, launched SYSTANE PRO Preservative-Free (PF), an over-the-counter artificial tear with a triple-action formula to hydrate, restore, and protect dry eyes. Its innovative multi-dose, preservative-free design combines hyaluronate, nano-sized lipids, and HP-Guar, which work synergistically to provide deep hydration, restore tear film stability, and protect the ocular surface, delivering long-lasting relief for all types of dry eye while minimizing irritation even with frequent use.What Are Latest Mergers And Acquisitions In The Over-The-Counter (OTC) Artificial Tears Market?
In July 2023, Bausch + Lomb Corporation, a Canada-based eye health company, acquired the Blink OTC eye drop product line from Johnson & Johnson Vision for $106.5 million. Through this acquisition, Bausch + Lomb aims to strengthen its over-the-counter eye care portfolio by adding the Blink line of artificial tears and rewetting drops, expanding consumer access to trusted solutions for dry eye and contact lens discomfort. Johnson & Johnson Vision is a US-based eye health solutions company that manufactures over-the-counter artificial tears, offering products for dry eye relief and contact lens comfort.Regional Insights
North America was the largest region in the over-the-counter (OTC) artificial tears market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Over-The-Counter (OTC) Artificial Tears Market?
The over-the-counter (OTC) artificial tears market consists of sales of hyaluronic acid-based tears, electrolyte-based tears, vitamin-enriched tears, medium viscosity tears, and high viscosity tears. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Over-The-Counter (OTC) Artificial Tears Market Report 2026?
The over-the-counter (otc) artificial tears market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the over-the-counter (otc) artificial tears industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Over-The-Counter (OTC) Artificial Tears Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $5.24 billion |
| Revenue Forecast In 2035 | $6.53 billion |
| Growth Rate | CAGR of 6.1% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Container Type, Formulation, Application, Distribution Channel |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | AbbVie Inc., Abbott Laboratories Inc., Novartis AG, Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Cipla Limited, Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical Co. Ltd., Prestige Consumer Healthcare Inc., AFT Pharmaceuticals Limited, URSAPHARM Arzneimittel GmbH, OCuSOFT Inc., Laboratoires Théa S.A.S., I-MED Pharma Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
